| |
Genotypes
|
Allele frequencies
|
---|
|
n.
|
GG
|
GA
|
AA
|
G
|
A
|
---|
Total obese subjects*
|
115
|
87 (75.6%)
|
26 (22.6%)
|
2 (1.8%)
|
0.869
|
0.131
|
– Central obesity
#
|
61
|
50 (81.9%)
|
11 (18,1%)
|
-
|
0.909
|
0.091
|
– Peripheral obesity
§
|
37
|
28 (75.6%)
|
9 (24.4)
|
-
|
0.878
|
0.122
|
Lean subjects
|
79
|
58 (73.4%)
|
19 (24.%)
|
2 (2.%)
|
0.854
|
0.146
|
- GG, GA, and AA = TNF-α genotypes. Total obese subjects includes 17 patients whom did not undergo biolectric impedance analysis * Total obese subjects vs controls: genotypes Χ2 = 0.21, df = 2, p < NS; allele frequencies Χ2 = 0.09, df = 1, p < NS. # Central obese subjects vs controls: genotypes Χ2 = 2.4, df = 2, p < NS; allele frequencies Χ2 = 1.4, df = 1, p < NS. § Peripheral obese subjects vs controls: genotypes Χ2 = 0.95, df = 2, p < NS; allele frequencies Χ2 = 0.16, df = 1, p < NS. Central obese subjects vs peripheral obese subjects: genotypes Χ2 = 0.5, df = 1, p = NS; allele frequencies Χ2 = 0.4, df = 1, p = NS. Cutpoints for centrally obese subjects were : WC 94 for men and WC 88 for women